Inhaled nitric oxide delivery and monitoring

Journal of Clinical Monitoring and Computing

Volumn 15, Issue 5, 1999, Pages 325-335

  Montgomery, Frederick J ^a   Berssenbrugge, Anne D ^a  

^a Datex Ohmeda   (United States)

Author keywords

Chemiluminescent analyzer; Electrochemical cell analyzer; Equipment; Measurement techniques; Monitoring; Nitric oxide; Nitric oxide delivery system; Nitrogen dioxide

Indexed keywords

BIOMEDICAL EQUIPMENT; CHEMILUMINESCENCE; ELECTROCHEMISTRY; NITROGEN OXIDES;

CHEMILUMINESCENT ANALYZER; ELECTROCHEMICAL CELL ANALYZER;

PATIENT MONITORING;

NITRIC OXIDE; NITROGEN DIOXIDE; OXYGEN;

CHEMOLUMINESCENCE; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; ELECTROCHEMISTRY; FLOW MEASUREMENT; FOOD AND DRUG ADMINISTRATION; GAS MIXING; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTENSIVE CARE UNIT; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; SAFETY; VASODILATATION; VENTILATOR; ANESTHESIOLOGY; ARTICLE; INSTRUMENTATION; MONITORING;

ADMINISTRATION, INHALATION; ANESTHESIOLOGY; HUMANS; MONITORING, PHYSIOLOGIC; NITRIC OXIDE; VENTILATORS, MECHANICAL;

EID: 0032750202     PISSN: 13871307     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009920724708     Document Type: Review

References (33)

1. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987; 84: 9265-9269
2. Higenbottam T, Pepke-Zaba J, Scott J, Woolman P, Coutts C, Wallwork J. Inhaled endothelium derived relaxing factor (EDRF) in primary pulmonary hypertension (PPH). Am Rev Respirat Dis 1988; 137: 107
3. Kinsella JP, Neish SR, Shaffer E, Abman S. Low-dose Inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340: 819-820
4. Roberts JD, Polaner DM, Lang P, Zapol WM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340: 818-819
5. Rossaint R, Falke KJ, Lopez F, Slama K, Pison LJ, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993; 328: 399-405
6. Rich G, Murphy GD, Roos CM, Johns RA. Inhaled nitric oxide. Selective pulmonary vasodilation in cardiac surgical patients. Anesthesiology 1993; 78: 1028-1035
7. Roberts JD, Lang P, Bigatello LM, Vlahakes GJ, Zapol WM. Inhaled nitric oxide in congenital heart disease. Circulation 1993; 87: 447-453
8. Wessel DL, Adatia I, Thompson JE, Hickey PR. Delivery and monitoring of inhaled nitric oxide in patients with pulmonary hypertension. Crit Care Med 1994; 22: 930-938
9. Imanaka H, Hess D, Kirmse M, Bigatello LM, Kacmarek RM, Steudel W, Hurford WE. Inaccuracies of nitric oxide delivery systems during adult mechanical ventilation. Anesthesiology 1997; 86: 676-688
10. Putensen C, Rasanen J, Thomson MS, Braman RS. Method of delivering constant nitric oxide concentrations during full and partial ventilatory support. J Clin Monit 1995; 11: 23-31
11. Nishimura M, Hess D, Kacmarek RM, Ritz R, Hurford WM. Nitrogen dioxide production during mechanical ventilation with nitric oxide in adults. Anesthesiology 1995; 82: 1246-1254
12. Glasson WA, Tuesday CS. Atmospheric thermal oxidation of nitric oxide. J Am Chem Soc 1963; 85: 2901-2904
13. Sokol GM, Van Meurs KP, Thorn WI, Rivera O, Chu P, Wright L, Sams RL. Limitations in nitrogen dioxide measurement with commercially available analyzers. Pediatr Res 1996; 39: 353A
14. Centers for Disease Control. NIOSH Recommendations for occupational safety and health standards. MMWR 1988; 37: 21
15. Federal Register. 'FDA advisory committees; Notice of meeting. Agenda of the anesthesia and respiratory therapy devices panel of the medical devices advisory committee which includes the proposed classifications and special controls for nitric oxide administration apparatus, nitric oxide gas analyzer and nitrogen dioxide gas analyzer. Federal Register 4 November 1996; 61 (214): 5688-5689
16. Davidson D, Barefield ES, Kattwinkel J, Dudell G, Damask M, Straube R, Rhines J, Chang C. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the newborn. Pediatrics 1998; 101: 325-334
17. Dellinger RP, Zimmerman JL, Taylor RW, Straube RC, Hauser DL, Criner GJ, Davis K, Hyers TM, Papadakos P. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome. Crit Care Med 1998; 26: 15-23
18. Stenquist O, Kjelltoft B, Lundin S. Evaluation of a new system for ventilatory administration of nitric oxide. Acta Anaesthiol Scand 1993; 37: 687-691
19. Zapol WM, Rimar S, Gillis N, Marletta M, Bosken CH. Nitric oxide and the lung. AmJ Respir Care Med 1994; 149: 1375-1380
20. Frostell C. Nitric oxide inhalation - future drug or an invitation to disaster? Pediatr Anaesth 1994; 4: 147-150
21. Medical Products Agency of Sweden. Medical Products Agency guidelines for the authorized use of NO in conjunction with ventilator treatment. 20 January 1995
22. Girard C, Durand PG, Vedrinne C, Pannetier, JC, Estanove S, Falke K, Adnot S, Lemaire F. Case 4 1993. Inhaled nitric oxide for right ventricular failure after heart transplantation. J Cardiothorac Vase Anesth 1993; 7: 481-485
23. Petros AJ. Down-regulation of endogenous nitric oxide production after prolonged administration. Lancet 1994; 244: 191
24. Young JD, Roberts M, Gale LB. Laboratory evaluation of the INOvent nitric oxide delivery device. Br J Anaesth 1997; 79: 398-401
25. Body SC, Hartigan PM Shernan SK, Formanek V, Hurford WE. Nitric oxide: Delivery, measurement, and clinical application. J Cardiothorac Vase Anesth 1995: 9: 748-763
26. Bathe D, Berssenbrugge A, Kohlmann T, Montgomery F. Monitoring accuracy for the measurement of nitric oxide (NO) in the 0 to 80 ppm range. Crit Care Med 1996; 24: A103
27. Etches PC, Harris ML, McKinley R, Finer NN. Clinical monitoring of inhaled nitric oxide: Comparison of chemiluminescent and electrochemical sensors. BioMed Inst Tech 1995; 29: 134-140
28. Kirmse M, Hess D, Fujino Y, Kacmarek RM, Hurford WE. Delivery of inhaled nitric oxide using the Ohmeda INOvent delivery system. Chest 1998; 113: 1650-1657
29. Channick RN, Newhart JW, Johnson FW, Williams PJ, Auger WR, Fedullo PF, Moser KM. Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension. Chest 1996; 109: 1545-1549
30. Ivy DD, Griebel JL, Kinsella JP, Abman SH. Acute hemodynamic effects of pulsed delivery of low flow nasal nitric oxide in children with pulmonary hypertension. J Pediatr 1998; 133: 453-456
31. Yoshida M, Taguchi O, Gabazza EC, Yasui H, Kobayashi T, Kobayashi H, Maruyama K, Adachi Y. The effect of low-dose inhalation of nitric oxide in patients with pulmonary fibrosis. Eur Respir J 1997; 10: 2051-2054
32. Roger N, Barbera JA, Roca J, Rovira I, Gomez FP, Rodrigez-Roisin R. Nitric oxide inhalation during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 158: 800-806
33. Head CA, Brugnara C, Martinez-Ruiz R, Kacmarek RM, Bridges KR, Kuter D, Bloch KD, Zapol WM. Low concentrations of nitric oxide increase oxygen affinity of sickle erythrocytes in vitro and in vivo. J Clin Invest 1997; 100: 1193-1198